Appraisal of antivenom production in public laboratories in Latin America during the first semester of 2020: The impact of COVID-19

• José María Gutiérrez ,

  * E-mail: jose.gutierrez@ucr.ac.cr

  Affiliation Instituto Clodomiro Picado, Facultad de Microbiología, Universidad de Costa Rica, San José, Costa Rica

  https://orcid.org/0000-0001-8385-3081

  ⨯
• Larissa Zanette,

  Affiliation Centro Panamericano de Fiebre Aftosa, Organización Panamericana de la Salud, Rio de Janeiro, Brazil

  https://orcid.org/0000-0003-3690-3810

  ⨯
• Marco Antonio Natal Vigilato,

  Affiliation Centro Panamericano de Fiebre Aftosa, Organización Panamericana de la Salud, Rio de Janeiro, Brazil

  https://orcid.org/0000-0003-3920-0766

  ⨯
• Julio Cesar Augusto Pompei,

  Affiliation Centro Panamericano de Fiebre Aftosa, Organización Panamericana de la Salud, Rio de Janeiro, Brazil

  ⨯
• Diogo Martins,

  Affiliation Wellcome Trust, London, United Kingdom

  https://orcid.org/0000-0002-9795-0787

  ⨯
• Hui Wen Fan,

  Affiliation Instituto Butantan, São Paulo, Brazil

  https://orcid.org/0000-0002-8191-559X

  ⨯
• the Latin American Network of Public Antivenom Manufacturing Laboratories (RELAPA)